"I spent many years believing misinformation online about the role of high ApoB in heart disease. When I finally broke free from that delusion, I realized that the scientific evidence overwhelmingly supports its causal link beyond any reasonable doubt. In my search for ways to assess and treat my risk factors, I came across Instalab.

The experience has been truly life-changing.

Over several months of testing and tweaking my medication, I've lowered my ApoB to 60 mg/dL, placing me in a very low-risk category. The sense of relief is incredible, knowing I've addressed a major threat that kills so many of us prematurely and unnecessarily.

Beyond that, Instalab helped me tackle other risk factors, including low B12 and B9 levels, which had been driving up my homocysteine, a key contributor to cardiovascular disease. I believe this intervention also cured the chronic joint issues that plagued me for decades.

It's clear that this kind of preventative medicine, going beyond just treating existing illness, is the future of healthcare."